Background
The discovery that melanocortin peptides influence sexual behavior emerged from observations that ACTH and α-MSH analogues produced spontaneous erections in rats and increased grooming behaviors consistent with sexual arousal. Pfaus and colleagues at Concordia University, in collaboration with Palatin Technologies, conducted a systematic mechanistic investigation of how bremelanotide (PT-141) produces its pro-sexual effects through melanocortin receptor circuits.
Understanding the neural substrates was critical for explaining why PT-141 works in populations where peripheral vascular agents fail and for establishing its safety profile relative to direct dopamine agonists.
Key Findings
Receptor Specificity:
- PT-141 has high affinity for MC3R and MC4R (Ki ~ 0.3–0.9 nM) with significantly lower affinity for MC1R (skin) and MC5R
- MC4R knockout mice show complete abolition of PT-141’s pro-erectile effects, confirming MC4R as the primary target
- MC3R role: modulates appetitive sexual motivation and anxiety reduction that facilitates approach behavior
Neural Circuit Mapping:
- Paraventricular nucleus (PVN): Central site for PT-141’s erectile effects; microinjection of MC4R agonists into PVN produces dose-dependent erection in rats
- Medial preoptic area (MPOA): Critical for sexual motivation and coordination; MC4R activation here increases dopamine release in nucleus accumbens
- Nitric oxide pathway: PVN MC4R → neuronal NOS (nNOS) → NO → downstream penile/clitoral vascular response — distinct from the peripheral cGMP pathway of PDE5 inhibitors
Female Sexual Response:
- In ovariectomized estrogen-primed rats, PT-141 significantly increased lordosis quotient (female sexual receptivity) at doses of 1–3 mg/kg
- Selective facilitation of solicitation behaviors (proceptive hops and darts) — a marker of appetitive sexual motivation — occurred at doses below those producing full lordosis
- This appetitive specificity is mechanistically important for female HSDD, where desire deficits precede arousal deficits
Dopaminergic Interactions:
- PT-141 administration increased extracellular dopamine in the nucleus accumbens by ~40%, measured by microdialysis
- The dopaminergic component contributes to the motivational/reward aspect of the sexual response
- Unlike direct dopamine agonists, this effect is upstream and context-modulated (not tonic stimulation)
Mechanistic Framework
PT-141 (bremelanotide)
↓ MC3R/MC4R (hypothalamus: PVN, MPOA)
↓
Nitric oxide synthesis (nNOS) + Dopamine release (NAc)
↓ ↓
Vascular response Sexual motivation/
(penile/clitoral) reward salience
↓ ↓
Erection/engorgement Desire, appetitive
behavior, approach
Clinical Significance
- Explains efficacy in psychogenic dysfunction: Central initiation of desire and arousal is mechanistically appropriate for HSDD and psychogenic ED where the primary deficit is motivational rather than vascular
- Explains PDE5 non-responder activity: Men who lack sufficient peripheral cGMP amplification may still respond to upstream central NO and vascular signaling from the PVN pathway
- Context-dependency: MC4R’s role in social salience means PT-141 works within a sexually relevant context — it does not produce indiscriminate arousal, reducing abuse liability
- Female HSDD mechanism: The appetitive/desire-specific circuit activation in females provided the mechanistic basis for the RECONNECT Phase III program
Limitations
- Primarily animal (rat) data — direct extrapolation to human CNS melanocortin circuit anatomy requires caution
- Optogenetic and chemogenetic tools to confirm these circuits in primates/humans were not available at the time
- Dose-response relationships in animal models don’t translate directly to human pharmacokinetics
- The relative contribution of MC3R vs. MC4R in humans has not been definitively established